[Subject to FRE 408 and Other Similar Rules ConfidentialExchange Offer Term Sheet (Cont.)New Money Oversubscription Right Each bondholder participating in the new money investment shall have the right to subscribe to additional amounts in excess of its pro rata allocation Oversubscription Amount: 3.0]
[Termination agreement of “Exclusive Business Cooperation Agreement,” “Exclusive Option Agreement,” “Share Pledge Agreement,” “Timely Reporting Agreement,” and “Powers of Attorney” Agreement Parties This Termination Agreement (the “ Hao Limo (1) Hao Limo Technology (Beijing) Co., Ltd. (the “ Huamuche]
[Subject to FRE 408 and Other Similar Rules ConfidentialExchange Offer Term Sheet (Cont.)New Money Oversubscription Right Each bondholder participating in the new money investment shall have the right to subscribe to additional amounts in excess of its pro rata allocation Oversubscription Amount: 3.0]
[Termination agreement of “Exclusive Business Cooperation Agreement,” “Exclusive Option Agreement,” “Share Pledge Agreement,” “Timely Reporting Agreement,” and “Powers of Attorney” Agreement Parties This Termination Agreement (the “ Hao Limo (1) Hao Limo Technology (Beijing) Co., Ltd. (the “ Huamuche]
[By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 29 June 2020 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Directors; and Zheng Fan,]
[By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 29 June 2020 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Directors; and Zheng Fan,]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[China HGS will launch the construction of the Liangzhou road real estate project in the second half of 2020 HANZHONG, CHINA – June 29, 2020 – China HGS Real Estate, Inc. (NASDAQ: HGSH) (“China HGS” or the “Company”), a leading regional real estate developer headquartered in Hanzhong City, Shaanxi Pr]
